Article
Generation of induced pluripotent stem cell lines from two unrelated individuals with familial hypertrophic cardiomyopathy carrying MYBPC3 nonsense mutations.
Stem cell research - 1 Apr 2024
Ribeiro Marta, Jager Joanna, Furtado Marta, Carvalho Teresa, Cabral Joaquim M S, Brito Dulce, Carmo-Fonseca Maria, Martins Sandra, da Rocha Simão Teixeira
Abstract excerpt
Familial hypertrophic cardiomyopathy (HCM) stands as a predominant heart condition, characterised by left ventricle hypertrophy in the absence of any associated loading conditions, with affected individuals having an increased risk of developing heart failure and sudden cardiac death (SCD). Two induced pluripotent stem cell (iPSC) lines were derived from peripheral blood mononuclear cells obtained from two...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
